Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

19 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical effectiveness of routine first-trimester combined screening for pre-eclampsia in Spain with the addition of placental growth factor.
Garcia-Manau P, Bonacina E, Serrano B, Caamiña S, Ricart M, Lopez-Quesada E, Vives À, Lopez M, Pintado E, Maroto A, Catalan S, Dalmau M, Del Barco E, Hernandez A, Miserachs M, San Jose M, Armengol-Alsina M, Carreras E, Mendoza M. Garcia-Manau P, et al. Among authors: lopez quesada e. Acta Obstet Gynecol Scand. 2023 Dec;102(12):1711-1718. doi: 10.1111/aogs.14687. Epub 2023 Oct 9. Acta Obstet Gynecol Scand. 2023. PMID: 37814344 Free PMC article.
Implementation of routine first-trimester combined screening for preeclampsia based on the Gaussian algorithm: A clinical effectiveness study.
Mendoza M, Bonacina E, Serrano B, Ricart M, Martin L, Lopez-Quesada E, Vives A, Maroto A, Garcia-Manau P, De Antonio C, Tusquets C, Moreano G, Armengol-Alsina M, Carreras E. Mendoza M, et al. Among authors: lopez quesada e. Int J Gynaecol Obstet. 2022 Dec;159(3):803-809. doi: 10.1002/ijgo.14192. Epub 2022 Apr 8. Int J Gynaecol Obstet. 2022. PMID: 35332556
Shared risk factors for COVID-19 and preeclampsia in the first trimester: An observational study.
Serrano B, Mendoza M, Garcia-Aguilar P, Bonacina E, Garcia-Ruiz I, Garcia-Manau P, Gil J, Armengol-Alsina M, Fernandez-Hidalgo N, Sulleiro E, Lopez-Martinez RM, Ricart M, Martin L, Lopez-Quesada E, Vives A, Maroto A, Maiz N, Suy A, Carreras E. Serrano B, et al. Among authors: lopez quesada e. Acta Obstet Gynecol Scand. 2022 Jul;101(7):803-808. doi: 10.1111/aogs.14371. Epub 2022 May 3. Acta Obstet Gynecol Scand. 2022. PMID: 35505629 Free PMC article.
The Fetal Growth Restriction at Term Managed by Angiogenic Factors Versus Feto-Maternal Doppler (GRAFD) Trial to Avoid Adverse Perinatal Outcomes: Protocol for a Multicenter, Open-Label, Randomized Controlled Trial.
Garcia-Manau P, Mendoza M, Bonacina E, Martin-Alonso R, Martin L, Palacios A, Sanchez ML, Lesmes C, Hurtado I, Perez E, Tubau A, Ibañez P, Alcoz M, Valiño N, Moreno E, Borrero C, Garcia E, Lopez-Quesada E, Diaz S, Broullon JR, Teixidor M, Chulilla C, Gil MM, Lopez M, Candela-Hidalgo A, Salinas-Amoros A, Moreno A, Morra F, Vaquerizo O, Soriano B, Fabre M, Gomez-Valencia E, Cuiña A, Alayon N, Sainz JA, Vives A, Esteve E, Ocaña V, López MÁ, Maroto A, Carreras E. Garcia-Manau P, et al. Among authors: lopez quesada e. JMIR Res Protoc. 2022 Oct 11;11(10):e37452. doi: 10.2196/37452. JMIR Res Protoc. 2022. PMID: 36222789 Free PMC article.
Aspirin Discontinuation at 24 to 28 Weeks' Gestation in Pregnancies at High Risk of Preterm Preeclampsia: A Randomized Clinical Trial.
Mendoza M, Bonacina E, Garcia-Manau P, López M, Caamiña S, Vives À, Lopez-Quesada E, Ricart M, Maroto A, de Mingo L, Pintado E, Ferrer-Costa R, Martin L, Rodríguez-Zurita A, Garcia E, Pallarols M, Vidal-Sagnier L, Teixidor M, Orizales-Lago C, Pérez-Gomez A, Ocaña V, Puerto L, Millán P, Alsius M, Diaz S, Maiz N, Carreras E, Suy A. Mendoza M, et al. Among authors: lopez quesada e. JAMA. 2023 Feb 21;329(7):542-550. doi: 10.1001/jama.2023.0691. JAMA. 2023. PMID: 36809321 Free PMC article. Clinical Trial.
Mid-trimester uterine artery Doppler for aspirin discontinuation in pregnancies at high risk for preterm pre-eclampsia: Post-hoc analysis of StopPRE trial.
Bonacina E, Garcia-Manau P, López M, Caamiña S, Vives À, Lopez-Quesada E, Ricart M, Maroto A, de Mingo L, Pintado E, Castillo-Ribelles L, Martín L, Rodriguez-Zurita A, Garcia E, Pallarols M, Vidal-Sagnier L, Teixidor M, Orizales-Lago C, Pérez-Gomez A, Ocaña V, Puerto L, Millán P, Alsius M, Diaz S, Maiz N, Carreras E, Suy A, Mendoza M. Bonacina E, et al. Among authors: lopez quesada e. BJOG. 2024 Feb;131(3):334-342. doi: 10.1111/1471-0528.17631. Epub 2023 Aug 9. BJOG. 2024. PMID: 37555464
Placental growth factor at 24-28 weeks for aspirin discontinuation in pregnancies at high risk for preterm preeclampsia: Post hoc analysis of StopPRE trial.
Ricart M, Bonacina E, Garcia-Manau P, López M, Caamiña S, Vives À, Lopez-Quesada E, Maroto A, de Mingo L, Pintado E, Ferrer-Costa R, Martín L, Rodriguez-Zurita A, Garcia E, Pallarols M, Pratcorona L, Teixidor M, Orizales-Lago C, Ocaña V, Del Barco E, Carreras E, Suy A, Mendoza M. Ricart M, et al. Among authors: lopez quesada e. Acta Obstet Gynecol Scand. 2024 Nov;103(11):2273-2280. doi: 10.1111/aogs.14955. Epub 2024 Aug 22. Acta Obstet Gynecol Scand. 2024. PMID: 39171611 Free PMC article. Clinical Trial.
Next-Generation Sequencing Gene Panels and "Solo" Clinical Exome Sequencing Applied in Structurally Abnormal Fetuses.
Pauta M, Campos B, Segura-Puimedon M, Arca G, Nadal A, Tubau A, Perez SP, Marimon E, Martín L, López-Quesada E, Sabrià J, Muñoz B, Garcia E, Paz Y Miño F, Borobio V, Gomez O, Eixarch E, Lopez M, Comas Rovira M, Borrell A. Pauta M, et al. Among authors: lopez quesada e. Fetal Diagn Ther. 2021;48(10):746-756. doi: 10.1159/000519701. Epub 2021 Nov 12. Fetal Diagn Ther. 2021. PMID: 34775388 Free article.
19 results